TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
-19.06%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(-41%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-38.65%
Top 10 Holdings %
Top 10 Hldgs %
69.06%
Holding
41
New
12
Increased
4
Reduced
13
Closed
7
Top Buys
| 1 |
Perrigo
PRGO
|
$19.2M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
$10.5M |
| 3 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$6.99M |
| 4 |
Merck
MRK
|
$6.93M |
| 5 |
Viatris
VTRS
|
$6.71M |
Top Sells
| 1 |
Bio-Rad Laboratories Class A
BIO
|
$21M |
| 2 |
Zimmer Biomet
ZBH
|
$18.6M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$18.6M |
| 4 |
Johnson & Johnson
JNJ
|
$18M |
| 5 |
Medtronic
MDT
|
$14.4M |
Sector Composition
| 1 | Healthcare | 92.73% |
| 2 | Technology | 6.73% |
| 3 | Financials | 0.54% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Quest Diagnostics
DGX
$20.3B
| $25.5M | 9.64% | 317,000 +72,000 | +29% | +$5.78M |
|
|
2
Medtronic
MDT
$119B
| $20.3M | 7.68% | 225,000 -160,000 | -42% | -$14.4M |
|
3
AtriCure
ATRC
$1.84B
| $20.2M | 7.63% | 600,000 -260,000 | -30% | -$8.73M |
|
|
MDRX
4
DELISTED
Veradigm Inc. Common Stock
MDRX
| $19.8M | 7.49% | 2,810,000 -840,000 | -23% | -$5.91M |
|
|
5
Perrigo
PRGO
$3.27B
| $19.2M | 7.28% | +400,000 | New | +$19.2M |
|
6
Pacira BioSciences
PCRX
$1.2B
| $18.4M | 6.98% | 550,000 -72,500 | -12% | -$2.43M |
|
7
United Therapeutics
UTHR
$13.8B
| $15.3M | 5.78% | 161,000 +9,600 | +6% | +$910K |
|
|
8
Bio-Rad Laboratories Class A
BIO
$8.06B
| $14M | 5.31% | 40,000 -60,000 | -60% | -$21M |
|
|
9
Viatris
VTRS
$12.3B
| $13.4M | 5.08% | 900,000 +450,000 | +100% | +$6.71M |
|
10
Hologic
HOLX
$14.9B
| $13.3M | 5.05% | 380,000 -95,000 | -20% | -$3.33M |
|
|
NUAN
11
DELISTED
Nuance Communications, Inc.
NUAN
| $10.5M | 3.97% | +625,000 | New | +$10.5M |
|
12
Rigel Pharmaceuticals
RIGL
$697M
| $8.66M | 3.28% | 5,550,000 -200,000 | -3% | -$312K |
|
|
CHNG
13
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $6.99M | 2.65% | +700,000 | New | +$6.99M |
|
|
OPTN
14
DELISTED
OptiNose
OPTN
| $6.96M | 2.64% | 1,550,000 +500,000 | +48% | +$2.25M |
|
|
15
Merck
MRK
$210B
| $6.93M | 2.62% | +90,000 | New | +$6.93M |
|
16
Phreesia
PHR
$1.88B
| $5.26M | 1.99% | 250,000 -410,000 | -62% | -$8.62M |
|
|
ISEE
17
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.3M | 1.63% | 1,250,000 -1,400,000 | -53% | -$4.82M |
|
|
PGNX
18
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $4.18M | 1.58% | +1,100,000 | New | +$4.18M |
|
|
STRM
19
DELISTED
Streamline Health Solutions
STRM
| $3.66M | 1.39% | 4,305,882 | – | – |
|
20
Becton Dickinson
BDX
$55.3B
| $3.45M | 1.31% | +15,000 | New | +$3.45M |
|
21
Pfizer
PFE
$141B
| $3.26M | 1.24% | +100,000 | New | +$3.26M |
|
22
Lantheus
LNTH
$3.73B
| $2.55M | 0.97% | 200,000 -450,000 | -69% | -$5.74M |
|
23
SI-BONE Inc
SIBN
$719M
| $2.47M | 0.94% | +207,000 | New | +$2.47M |
|
24
RadNet
RDNT
$5.52B
| $2.37M | 0.9% | 225,000 -175,000 | -44% | -$1.84M |
|
25
ICU Medical
ICUI
$3.15B
| $2.22M | 0.84% | 11,000 -59,000 | -84% | -$11.9M |
|